Optimal microbicidal activity of human polymorphonuclear leukocytes (PMN) relies on the generation of toxic agents such as hypochlorous acid (HOCl) in phagosomes. HOCl formation requires H2O2 produced by the NADPH oxidase, myeloperoxidase derived from azurophilic granules, and chloride ion. Chloride transport from cytoplasm into phagosomes requires chloride channels which include cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-activated chloride channel. However, the phagosomal targeting of CFTR in PMN has not been defined. Using human peripheral blood PMN, we determined that 95-99% of lysosomal-associated membrane protein 1 (LAMP-1)-positive mature phagosomes were CFTR positive, as judged by immunostaining and flow cytometric analysis. To establish a model cell system to evaluate CFTR phagosomal recruitment, we stably expressed enhanced green fluorescent protein (EGFP) alone, EGFP-wt-CFTR and EGFP-DF508-CFTR fusion proteins in promyelocytic PLB-985 cells, respectively. After differentiation into neutrophil-like cells, CFTR presentation to phagosomes was examined. EGFP-wt-CFTR was observed to associate with phagosomes and colocalize with LAMP-1. Flow cytometric analysis of the isolated phagosomes indicated that such a phagosomal targeting was determined by the CFTR portion of the fusion protein. In contrast, significantly less EGFP-DF508-CFTR was found in phagosomes, indicating a defective targeting of the molecule to the organelle. Importantly, the CFTR corrector compound VRT-325 facilitated the recruitment of DF508-CFTR to phagosomes. These data demonstrate the possibility of pharmacologic correction of impaired recruitment of mutant CFTR, thereby providing a potential means to augment chloride supply to the phagosomes of PMN in patients with cystic fibrosis to enhance their microbicidal function.

1.
Welsh MJ, Ramsey BW, Accurso F, Cutting G: Cystic fibrosis; in Scriver CR (ed): Metabolic and Molecular Basis of Inherited Disease. New York, McGraw-Hill, 2001, pp 5121-5188.
2.
Davis PB, Drumm M, Konstan MW: Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-1256.
[PubMed]
3.
Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B: Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? Mediators Inflamm 1999;8:7-11.
[PubMed]
4.
Downey DG, Bell SC, Elborn JS: Neutrophils in cystic fibrosis. Thorax 2009;64:81-88.
[PubMed]
5.
Hayes E, Pohl K, McElvaney NG, Reeves EP: The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 2011;59:97-112.
[PubMed]
6.
Ratner D, Mueller C: Immune responses in cystic fibrosis: are they intrinsically defective? Am J Respir Cell Mol Biol 2012;46:715-722.
[PubMed]
7.
Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, Descamps-Latscha B: Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 1996;157:2728-2735.
[PubMed]
8.
Witko-Sarsat V, Delacourt C, Rabier D, Bardet J, Nguyen AT, Descamps-Latscha B: Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med 1995;152:1910-1916.
[PubMed]
9.
Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG: Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol 2000;278:L33-L41.
[PubMed]
10.
Moriceau S, Lenoir G, Witko-Sarsat V: In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Immun 2010;2:260-266.
[PubMed]
11.
Hampton MB, Kettle AJ, Winterbourn CC: Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-3017.
[PubMed]
12.
Klebanoff SJ: Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77:598-625.
[PubMed]
13.
Nauseef WM: How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007;219:88-102.
[PubMed]
14.
Painter RG, Marrero L, Lombard GA, Valentine VG, Nauseef WM, Wang G: CFTR-mediated halide transport in phagosomes of human neutrophils. J Leukoc Biol 2010;87:933-942.
[PubMed]
15.
Painter RG, Valentine VG, Lanson NA Jr, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G: CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006;45:10260-10269.
[PubMed]
16.
Painter RG, Bonvillain RW, Valentine VG, Lombard GA, LaPlace SG, Nauseef WM, Wang G: The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol 2008;83:1345-1353.
[PubMed]
17.
Bonvillain RW, Painter RG, Adams DE, Viswanathan A, Lanson NA Jr, Wang G: RNA interference against CFTR affects HL60-derived neutrophil microbicidal function. Free Radic Biol Med 2010;49:1872-1880.
[PubMed]
18.
Phennicie RT, Sullivan MJ, Singer JT, Yoder JA, Kim CH: Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator. Infect Immun 2010;78:4542-4550.
[PubMed]
19.
Bonfield TL, Hodges CA, Cotton CU, Drumm ML: Absence of the cystic fibrosis transmembrane regulator (CFTR) from myeloid-derived cells slows resolution of inflammation and infection. J Leukoc Biol 2012;92:1111-1122.
[PubMed]
20.
Kutner RH, Zhang XY, Reiser J: Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009;4:495-505.
[PubMed]
21.
Nauseef WM, McCormick SJ, Clark RA: Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 1995;270:4741-4747.
[PubMed]
22.
Moyer BD, Loffing J, Schwiebert EM, Loffing-Cueni D, Halpin PA, Karlson KH, Ismailov, II, Guggino WB, Langford GM, Stanton BA: Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J Biol Chem 1998;273:21759-21768.
[PubMed]
23.
Granio O, Norez C, Ashbourne Excoffon KJ, Karp PH, Lusky M, Becq F, Boulanger P, Zabner J, Hong SS: Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells. Am J Respir Cell Mol Biol 2007;37:631-639.
[PubMed]
24.
Oceandy D, McMorran B, Schreiber R, Wainwright BJ, Kunzelmann K: GFP-tagged CFTR transgene is functional in the G551D cystic fibrosis mouse colon. J Membr Biol 2003;192:159-167.
[PubMed]
25.
Robert R, Carlile GW, Liao J, Balghi H, Lesimple P, Liu N, Kus B, Rotin D, Wilke M, de Jonge HR, Scholte BJ, Thomas DY, Hanrahan JW: Correction of the delta Phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine. Mol Pharmacol 2010;77:922-930.
[PubMed]
26.
Klebanoff SJ: Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970;169:1095-1097.
[PubMed]
27.
Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N: Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999;67:1828-1836.
[PubMed]
28.
Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Ishida-Okawara A, Suzuki K, Maeda N, Koyama H: Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans. J Med Microbiol 2006;55:1291-1299.
[PubMed]
29.
Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Maeda N, Koyama H: Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 2000;182:1276-1279.
[PubMed]
30.
Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ: Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 1981;95:293-301.
[PubMed]
31.
Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB: Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun 2009;77:5300-5310.
[PubMed]
32.
Bonvillain RW, Painter RG, Ledet EM, Wang G: Comparisons of resistance of CF and non-CF pathogens to hydrogen peroxide and hypochlorous acid oxidants in vitro. BMC Microbiol 2011;11:112.
[PubMed]
33.
Segal AW, Coade SB: Kinetics of oxygen consumption by phagocytosing human neutrophils. Biochem Biophys Res Commun 1978;84:611-617.
[PubMed]
34.
Winterbourn CC, Hampton MB, Livesey JH, Kettle AJ: Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 2006;281:39860-39869.
[PubMed]
35.
Painter RG, Wang G: Direct measurement of free chloride concentrations in the phagolysosomes of human neutrophils. Anal Chem 2006;78:3133-3137.
[PubMed]
36.
Aiken ML, Painter RG, Zhou Y, Wang G: Chloride transport in functionally active phagosomes isolated from human neutrophils. Free Radic Biol Med 2012;53:2308-2317.
[PubMed]
37.
Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ: Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992;358:761-764.
[PubMed]
38.
Mall M, Kreda SM, Mengos A, Jensen TJ, Hirtz S, Seydewitz HH, Yankaskas J, Kunzelmann K, Riordan JR, Boucher RC: The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 2004;126:32-41.
[PubMed]
39.
Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ: Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 1996;270:C1544-C1555.
[PubMed]
40.
Cholon DM, O'Neal WK, Randell SH, Riordan JR, Gentzsch M: Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 2010;298:L304-L314.
[PubMed]
You do not currently have access to this content.